Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ASH logo ASH
Upturn stock ratingUpturn stock rating
ASH logo

Ashland Global Holdings Inc (ASH)

Upturn stock ratingUpturn stock rating
$56.6
Last Close (24-hour delay)
Profit since last BUY5.11%
upturn advisory
Consider higher Upturn Star rating
BUY since 10 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: ASH (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

11 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $65.11

1 Year Target Price $65.11

Analysts Price Target For last 52 week
$65.11 Target price
52w Low $44.51
Current$56.6
52w High $87.09

Analysis of Past Performance

Type Stock
Historic Profit -17.07%
Avg. Invested days 30
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.59B USD
Price to earnings Ratio -
1Y Target Price 65.11
Price to earnings Ratio -
1Y Target Price 65.11
Volume (30-day avg) 11
Beta 0.48
52 Weeks Range 44.51 - 87.09
Updated Date 08/28/2025
52 Weeks Range 44.51 - 87.09
Updated Date 08/28/2025
Dividends yield (FY) 2.88%
Basic EPS (TTM) -17.97

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -46.07%
Operating Margin (TTM) 7.34%

Management Effectiveness

Return on Assets (TTM) 1.78%
Return on Equity (TTM) -34.43%

Valuation

Trailing PE -
Forward PE 12.17
Enterprise Value 3864957222
Price to Sales(TTM) 1.38
Enterprise Value 3864957222
Price to Sales(TTM) 1.38
Enterprise Value to Revenue 2.07
Enterprise Value to EBITDA 53.88
Shares Outstanding 45706000
Shares Floating 41773417
Shares Outstanding 45706000
Shares Floating 41773417
Percent Insiders 1.08
Percent Institutions 98.16

ai summary icon Upturn AI SWOT

Ashland Global Holdings Inc

stock logo

Company Overview

overview logo History and Background

Ashland Global Holdings Inc. was founded in 1924 as Ashland Refining Company. It evolved from a petroleum refiner to a specialty materials company, undergoing significant restructuring and divestitures over the years.

business area logo Core Business Areas

  • Life Sciences: Provides specialty ingredients and solutions for the pharmaceutical, nutraceutical, and personal care markets. Includes products like film formers, rheology modifiers, and delivery systems.
  • Specialty Additives: Offers a range of additives and functional ingredients for coatings, adhesives, construction, energy, and other industrial applications.
  • Intermediates: Produces chemicals for use in a variety of industries.

leadership logo Leadership and Structure

The company is led by Guillermo Novo (Chairman & CEO) and has a typical corporate structure with a board of directors and various executive leadership roles overseeing different business segments and functions.

Top Products and Market Share

overview logo Key Offerings

  • Benecelu2122: Methylcellulose polymers used in pharmaceutical and food applications; competitors include Dow and Shin-Etsu.
  • Aquaflowu2122: Rheology modifiers for waterborne coatings; competes with Elementis Specialties and BYK Additives & Instruments.
  • Viatelu2122: Bio-based polymers for various applications; competitors include DuPont and BASF.

Market Dynamics

industry overview logo Industry Overview

The specialty chemicals industry is characterized by innovation, regulatory compliance, and customer-specific solutions. Growth is driven by demand from various end markets such as pharmaceuticals, coatings, and personal care.

Positioning

Ashland holds a strong position in several niche markets, leveraging its technical expertise and application knowledge to provide differentiated products and services. Its competitive advantage lies in its focus on specialty ingredients and solutions.

Total Addressable Market (TAM)

The TAM for specialty chemicals is estimated to be in the hundreds of billions of dollars globally. Ashland is positioned to capture a portion of this market through its targeted approach and strong customer relationships.

Upturn SWOT Analysis

Strengths

  • Strong brand reputation
  • Technical expertise
  • Customer-centric approach
  • Diverse product portfolio
  • Global presence

Weaknesses

  • Exposure to cyclical industries
  • Dependence on key suppliers
  • Price volatility of raw materials
  • Integration challenges from acquisitions
  • Potential environmental liabilities

Opportunities

  • Expanding into emerging markets
  • Developing new applications for existing products
  • Acquiring complementary businesses
  • Leveraging digital technologies
  • Focusing on sustainable solutions

Threats

  • Economic downturns
  • Intense competition
  • Changing regulations
  • Technological disruptions
  • Fluctuations in currency exchange rates

Competitors and Market Share

competitor logo Key Competitors

  • DD
  • BASF
  • EMN

Competitive Landscape

Ashland's advantages include its specialty focus and strong customer relationships. Disadvantages include exposure to cyclical industries and dependence on key suppliers. Compared to competitors like Dow and BASF, Ashland is more specialized.

Major Acquisitions

Pharmachem

  • Year: 2017
  • Acquisition Price (USD millions): 660
  • Strategic Rationale: Expanded Ashland's presence in the nutraceuticals market.

Growth Trajectory and Initiatives

Historical Growth: Details on how the company grew in past years and the metrics used to show it, such as revenue and profit margin.

Future Projections: Based on Analyst estimates, we can detail what will drive growth for the company.

Recent Initiatives: Details on what the company did recently, such as expanding into different markets or R&D projects.

Summary

Ashland is a specialty materials company with a strong position in niche markets and customer centric solutions. Its diverse product portfolio has resulted in consistent growth, but it faces risks from the cyclical industries, price volatility of raw materials, and intense competition. Ashland should capitalize on opportunities in emerging markets and developing new applications for its products. The company has a well established track record of success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings
  • Industry reports
  • Analyst estimates

Disclaimers:

This analysis is for informational purposes only and should not be considered investment advice. Market conditions and company performance are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Ashland Global Holdings Inc

Exchange NYSE
Headquaters Wilmington, DE, United States
IPO Launch date 1983-04-06
Chairman & CEO Mr. Guillermo Novo
Sector Basic Materials
Industry Specialty Chemicals
Full time employees 2960
Full time employees 2960

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.